Evolution Biotechnologies is a privately held, Texas-based company (Registered USA No. 6050853) that has been established to build on unique experience and skillsets to bring phage therapy to market by the most efficient and cost-effective route.

By working to develop a commercial veterinary product for the high value companion animal sector, Evolution is focussed on establishing both proof of concept and a revenue stream. This will then support future human trials without the financial risk and investor dilution associated with progressing such work supported only by investment income. Evolution’s novel approach bypasses these risks.

The company is based in Austin, Texas.